Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Trivitron Healthcare...

    Trivitron Healthcare eyes Rs 750 crore revenue in Financial Year 2019

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-10-08T10:25:13+05:30  |  Updated On 16 Aug 2021 6:48 AM GMT

    New Delhi: Domestic medical devices maker Trivitron Healthcare is looking to clock revenue of around Rs 750 crore in the current fiscal year, as it mulls inorganic growth in key focus areas, a top company official has said. Established in 1997, the Chennai-based company posted revenue of around Rs 650 crore in the last fiscal year.


    "We are looking at a revenue of around Rs 750 crore for the current fiscal year," Trivitron Healthcare Chairman and MD GSK Velu told.

    Velu is the founder & Chairman of Trivitron Healthcare Group, Founder and Chairman of Neuberg Diagnostics and Maxivision Eye Care Hospitals, Founder and Managing Director of Apollo White Dental Ltd and Apollo Dialysis Clinics, the Joint Venture with Apollo Hospitals Group.


    The focus areas for the company are a laboratory, imaging, intensive care, operating rooms and renal dialysis, he added.

    Out of these, 80 per cent of the profits come from the areas of laboratory and imaging while others are emerging areas for the company, Velu said.

    "Going forward laboratory and imaging will continue to be the focus areas for the company where we are looking for both organic and inorganic growth to push revenues," he added.


    When asked about the key products manufactured by the company, Velu said the number one product for the group is for newborn screening.

    Other products are X-ray machines, ultrasound machines in a joint venture with Hitachi, mammography machines, all diagnostic products and products for intensive care units and operation theatres, he added.

    On being asked about the state of medical device sector in India, the intent is there but the gap between intent and action needs to be narrowed, Velu said, adding that the domestic medical device industry needs to be nurtured.

    Trivitron Healthcare currently has with 9 USFDA, CE manufacturing facilities across five locations -- Chennai, Mumbai, Pune, Ankara and Helsinki -- and has over 1,500 employees.

    Read Also:Trivitron Healthcare Launches Ultisys- Digital Radiography System at Arab Health 2017
    Apollo Hospitals GSK Velu mammography machines Maxivision Eye Care Hospitals Medical Devices Rs 750 crore Trivitron Healthcare USFDA x-ray machines 
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      X